Get the Stockscreener App
1.95
6.56%
0.12
After Hours:
1.89
-0.06
-3.08%
Biovie Inc stock is traded at $1.95, with a volume of 165.23K.
It is up +6.56% in the last 24 hours and up +4.28% over the past month.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
See More
Previous Close:
$1.83
Open:
$1.9
24h Volume:
165.23K
Relative Volume:
0.59
Market Cap:
$14.69M
Revenue:
-
Net Income/Loss:
$-25.56M
P/E Ratio:
-0.375
EPS:
-5.2
Net Cash Flow:
$-19.35M
1W Performance:
+4.28%
1M Performance:
+4.28%
6M Performance:
+150.00%
1Y Performance:
+65.25%
1-Day Range:
$1.85
$1.9598
1-Week Range:
$1.81
$2.05
52-Week Range:
$0.62
$9.56
Biovie Inc Stock (BIVI) Company Profile
Name
Biovie Inc
Sector
Industry
Phone
775-888-3162
Address
680 W NYE LANE, CARSON CITY
Compare BIVI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIVI
Biovie Inc
|
1.95 | 13.79M | 0 | -25.56M | -19.35M | -5.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Biovie Inc Stock (BIVI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-22-22 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-15-21 | Initiated | B. Riley Securities | Buy |
Biovie Inc Stock (BIVI) Latest News
Analyzing BioVie Inc. with multi timeframe chartsWeekly Trend Report & Daily Profit Focused Stock Screening - newser.com
Is it time to cut losses on BioVie Inc.Earnings Beat & AI Enhanced Execution Alerts - newser.com
Using data filters to optimize entry into BioVie Inc.2025 Valuation Update & Safe Capital Growth Tips - newser.com
Identifying reversal signals in BioVie Inc.Weekly Stock Summary & Weekly Market Pulse Alerts - newser.com
Can BioVie Inc. stock beat market expectations this quarterMarket Activity Report & Daily Oversold Bounce Ideas - newser.com
What analysts say about BioVie Inc stockStraddle and Strangle Trades & Outstanding Profit Strategies - earlytimes.in
What earnings revisions data tells us about BioVie Inc.Earnings Risk Report & Risk Managed Investment Entry Signals - newser.com
What momentum shifts mean for BioVie Inc.2025 Geopolitical Influence & Accurate Buy Signal Alerts - newser.com
How to recover losses in BioVie Inc. stockQuarterly Portfolio Summary & Target Return Focused Picks - newser.com
BioVie and FibroBiologics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Reno Gazette Journal
BIOVIE ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Multi asset correlation models including BioVie Inc.CEO Change & AI Forecasted Entry/Exit Points - newser.com
What moving averages say about BioVie Inc.Weekly Stock Summary & Consistent Profit Trade Alerts - newser.com
Can BioVie Inc. stock weather global recessionJuly 2025 Opening Moves & Safe Entry Zone Tips - newser.com
Visual analytics tools that track BioVie Inc. performanceJuly 2025 Final Week & Real-Time Stock Price Movement Reports - newser.com
Using data tools to time your BioVie Inc. exitJuly 2025 Highlights & Entry Point Confirmation Signals - newser.com
Transcript : BioVie Inc.Special Call - MarketScreener
Is BioVie Inc a good long term investmentEconomic Data Impact & Investment Risk Management Tips - earlytimes.in
Measuring BioVie Inc.’s beta against major indicesMarket Movement Recap & Daily Chart Pattern Signal Reports - newser.com
Intraday pattern recognizer results for BioVie Inc.2025 Valuation Update & High Conviction Buy Zone Alerts - newser.com
Applying chart zones and confluence areas to BioVie Inc.Earnings Beat & Verified High Yield Trade Plans - newser.com
Using portfolio simulators with BioVie Inc. included2025 Performance Recap & Risk Managed Trade Strategies - newser.com
BioVie Inc. stock daily chart insights2025 Stock Rankings & Long-Term Safe Investment Plans - newser.com
What the charts say about BioVie Inc. today2025 Retail Activity & Free Accurate Trade Setup Notifications - newser.com
Is BioVie Inc. stock positioned for digital transformationJuly 2025 Snapshot & Stock Portfolio Risk Control - newser.com
Will breakout in BioVie Inc. lead to full recovery2025 Technical Overview & Daily Stock Trend Watchlist - newser.com
What drives BioVie Inc stock pricePrice-to-Earnings Ratio Insights & Budget Friendly Trading Strategies - earlytimes.in
How to use Fibonacci retracement on BioVie Inc.Weekly Trade Analysis & Safe Swing Trade Setups - newser.com
Combining price and volume data for BioVie Inc.July 2025 Reactions & Free Daily Entry Point Trade Alerts - newser.com
Biovie Inc Stock (BIVI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):